# Humacyte, Inc.: Form 8-K, filed Nov 14, 2024

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 21:30 ET
- Period: 2024-11-13
- Accession: 0001104659-24-119013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/tm2428460d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/tm2428460d1_8k.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-119013. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.